The azacitidine plus romidepsin clinical trial in lymphoid malignancies
Novel immunotherapies and liquid biopsies - highlights from iwNHL 2016
Overview of new combinaton therapies in acute myeloid leukemia (AML)
Naval G. Daver
Highlights of ASH in CLL
John Gribben et al.
The first in-human Phase I study of a BET inhibitor for the treatment of NHL